_edited.png)
Vedanta Ltd
Vedanta Hits Record High - Why Analysts See the Stock Crossing ₹800 Next
Vedanta shares touched a record high as brokerage firm Nuvama Institutional Equities raised its price target to ₹806, the highest on the Street. Backed by demerger-led value unlocking, strong commodity prices, and sharp EBITDA growth expectations, Vedanta has emerged as one of the strongest large-cap performers, with zero “sell” ratings among analysts.
Street Turns Increasingly Bullish
Vedanta has received its most optimistic valuation yet, with Nuvama maintaining a “buy” rating and raising its target price by 18% to ₹806 from ₹686. This implies a potential upside of nearly 27% from recent levels. Notably, none of the 14 analysts tracking Vedanta currently have a “sell” rating—10 recommend “buy” while the rest suggest “hold,” highlighting strong consensus confidence.
Demerger Seen as Major Value Unlocker
A key driver behind the rally is Vedanta’s ongoing demerger plan, under which the company will split into five separately listed entities. According to Nuvama, Vedanta is in the final stages of securing statutory approvals. The brokerage believes this restructuring will unlock significant shareholder value, as individual businesses will be independently valued rather than being bundled under a holding-company discount.
Commodity Cycle and Earnings Upgrades
Strong aluminium and zinc prices have materially improved Vedanta’s earnings outlook. Nuvama has upgraded its EBITDA estimates by 17% for FY27 and 8% for FY28, factoring in higher commodity prices, cost reductions, and volume growth. As a result, Vedanta’s EBITDA is now expected to grow at a robust CAGR of 20% between FY25 and FY28.
Valuation Comfort and Market Momentum
The brokerage also noted that Vedanta’s current market price does not fully reflect the value of its aluminium and zinc businesses, effectively offering other verticals at minimal valuation. The stock is up 36% in 2025 so far, marking its second consecutive year of positive returns. It has risen for five straight months and is up nearly 10% this month alone, underlining sustained market momentum.
Investor Takeaway
With a rare combination of zero sell ratings, structural value unlocking through demerger, and a favourable commodity cycle, Vedanta’s rally appears to be driven by fundamentals rather than sentiment alone. The Street’s growing conviction explains why the stock continues to make new highs—and why the ₹800 level is now firmly on investors’ radar.
Latest News
PFC transfers Pune transmission project SPV to Power Grid after competitive bidding
Power Finance Corporation’s consulting arm has transferred the project SPV for a transmission expansion scheme in Maharashtra to Power Grid Corporation after it emerged as the winning bidder. The move follows the standard tariff-based competitive bidding framework used for developing power transmission infrastructure.
1:19 pm
13 March 2026
NCLT clears India Cements merger plan to simplify group structure
The National Company Law Tribunal has approved the amalgamation of four subsidiaries with India Cements. The restructuring is aimed at simplifying the corporate structure and improving administrative efficiency across the group.
1:14 pm
13 March 2026
US court ruling on Mirabegron generic strengthens outlook for Zydus and Lupin
A Delaware federal court has blocked Ascent Pharmaceuticals from launching a generic version of Mirabegron until the underlying patent expires. The decision delays competitive entry and strengthens revenue visibility for Zydus Lifesciences and Lupin in the US market.
12:04 pm
13 March 2026
India moves diplomatically to secure Hormuz route as LPG shipments and merchant vessels face disruption
India has initiated diplomatic engagement with Iran to ensure safe passage for LPG shipments and Indian merchant vessels stranded near the Strait of Hormuz amid escalating regional tensions. The move reflects growing concerns over energy security and shipping safety as the conflict in West Asia threatens one of the world’s most critical energy corridors.
10:51 am
13 March 2026
US China tariff and Taiwan tensions dominate Paris talks ahead of Trump Xi summit
Senior officials from the United States and China are set to meet in Paris to prepare the agenda for a high-stakes summit between President Donald Trump and President Xi Jinping later this month in Beijing. The negotiations will focus on tariffs, semiconductor exports, fentanyl trade concerns and Taiwan, issues that continue to define the fragile balance between cooperation and rivalry between the world’s two largest economies.